2012 annual financial data
Iovance Biotherapeutics 2012 Net margin
Iovance Biotherapeutics 2012 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -8,132,546 USD and net income was -3,307,619 USD.
Operating cash flow was -2,241,467 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,132,546 USD
- Net income
- -3,307,619 USD
- Operating cash flow
- -2,241,467 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Iovance Biotherapeutics financial years